Last reviewed · How we verify

ALK Grass tablet

ALK-Abelló A/S · Phase 3 active Biologic

ALK Grass tablet is an allergen immunotherapy that desensitizes the immune system to grass pollen allergens through gradual exposure.

ALK Grass tablet is an allergen immunotherapy that desensitizes the immune system to grass pollen allergens through gradual exposure. Used for Grass pollen-induced allergic rhinitis and/or allergic asthma.

At a glance

Generic nameALK Grass tablet
SponsorALK-Abelló A/S
Drug classAllergen immunotherapy (sublingual tablet)
TargetGrass pollen allergens (multiple epitopes)
ModalityBiologic
Therapeutic areaImmunology / Allergy
PhasePhase 3

Mechanism of action

This sublingual immunotherapy tablet contains standardized grass pollen allergen extract designed to induce immune tolerance. By administering small, gradually increasing doses of the allergen under the tongue, the treatment shifts the immune response from allergic (Th2-mediated) to tolerant (Th1/Treg-mediated), reducing allergic symptoms upon natural grass pollen exposure.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results